Investor Type
LinkedIn View on LinkedIn
Joy Ghosh is a senior research analyst at Eventide Asset Management.
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
obfuscated obfuscation | Korro Bio | Eventide | Series B - Korro Bio | obfuscated obfuscation | |
obfuscated obfuscation | LEXEO Therapeutics | Eventide | Series B - LEXEO Therapeutics | obfuscated obfuscation | |
obfuscated obfuscation | Arch Oncology | Eventide | Series C - Arch Oncology | obfuscated obfuscation | |
obfuscated obfuscation | Biosplice Therapeutics | Eventide | Venture Round - Biosplice Therapeutics | obfuscated obfuscation | |
obfuscated obfuscation | Prometheus Biosciences | Eventide | Private Equity Round - Prometheus Biosciences | obfuscated obfuscation | |
obfuscated obfuscation | Goldfinch Biopharma | Eventide | Series B - Goldfinch Biopharma | obfuscated obfuscation |